Resolving metabolic interactions between the gut microbiota and the host with multi-omics-based modelling
This project aims to systematically characterize gut bacteria interactions and their metabolic contributions to host health using experimental and computational methods, enabling targeted microbiota interventions.
Projectdetails
Introduction
The gut microbiota is essential to human health: microorganisms in the human body help to digest nutrients, engage in host metabolism, immunity, behaviour, and brain functions. Since the gut microbiota, in contrast to the human genome, can be modified through dietary and therapeutic interventions, modulating the microbiota is a promising path to improve human health and to prevent or treat diseases.
Challenges in Understanding Microbiota
However, predicting the effects of microbiota perturbations on the host metabolic phenotype remains extremely challenging due to our limited understanding of:
- Bacterial metabolic functions
- Molecular interactions within microbial communities
- The mechanisms of microbial interactions with the host
Proposed Approach
I propose to tackle these challenges with a combination of experimental and computational approaches in a synthetic community of 14 common human gut bacteria, which has been associated with over 150 health-relevant metabolites involved in amino acid, vitamin, and hormone metabolism in vivo.
Methodology
We will follow a bottom-up strategy to:
i) Systematically characterize the capacity of single bacteria to consume and produce metabolites of interest and identify the responsible enzymes.
ii) Investigate the metabolism of these compounds in compositionally diverse synthetic communities.
iii) Quantify and modulate microbiota contribution to the host metabolism of these compounds in mouse models.
Techniques and Integration
To this aim, we will combine:
- High-throughput bacterial culturing
- Metabolomics
- Transcriptomics
- Proteomics assays
- Genome-scale metabolic modelling
- Graph-based multi-omics integration methods
- Physiology-based models of microbiota-host interactions
Expected Outcomes
This project will provide a generalized framework to systematically resolve microbiota contributions to the host metabolic phenotype and elucidate the fundamental principles governing microbiota-host metabolic interactions. Thus, enabling targeted microbiota interventions to modulate the host metabolic phenotype and improve human health.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.499.323 |
Totale projectbegroting | € 1.499.323 |
Tijdlijn
Startdatum | 1-1-2024 |
Einddatum | 31-12-2028 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- EUROPEAN MOLECULAR BIOLOGY LABORATORYpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Gut microbiota drug biotransformation as a tool to unravel the mechanisms of metabolic microbiota-host interactionsThis project aims to systematically study metabolic interactions between gut microbiota and hosts using drug biotransformation to improve understanding of microbiome-related health variations and drug responses. | ERC Starting... | € 1.894.858 | 2023 | Details |
Proteome-wide Functional Interrogation and Modulation of Gut Microbiome SpeciesThis project aims to identify and manipulate gut microbiome protein functions using high-throughput proteomics to develop targeted therapies for restoring microbial health. | ERC Starting... | € 1.499.980 | 2023 | Details |
Microbial ecosystems biology in the human gutThis project aims to develop a comprehensive ecosystem model of child gut microbiota using multiomic data to predict and manipulate microbial responses for improved health interventions. | ERC Starting... | € 1.485.413 | 2023 | Details |
Dissection of the host-microbe crosstalk that controls metabolism and physiology in intestinal symbiosisThis project aims to explore the regulatory mechanisms of intestinal bacteria and their symbiotic relationship with hosts using Drosophila to enhance understanding of gut metabolism and health. | ERC Starting... | € 1.499.600 | 2023 | Details |
T cell regulation by fed state bacterial metabolitesThis project aims to identify immunoregulatory bacterial molecules produced in response to food intake, enhancing understanding of gut microbiome tolerance mechanisms and their impact on intestinal health. | ERC Starting... | € 1.499.548 | 2024 | Details |
Gut microbiota drug biotransformation as a tool to unravel the mechanisms of metabolic microbiota-host interactions
This project aims to systematically study metabolic interactions between gut microbiota and hosts using drug biotransformation to improve understanding of microbiome-related health variations and drug responses.
Proteome-wide Functional Interrogation and Modulation of Gut Microbiome Species
This project aims to identify and manipulate gut microbiome protein functions using high-throughput proteomics to develop targeted therapies for restoring microbial health.
Microbial ecosystems biology in the human gut
This project aims to develop a comprehensive ecosystem model of child gut microbiota using multiomic data to predict and manipulate microbial responses for improved health interventions.
Dissection of the host-microbe crosstalk that controls metabolism and physiology in intestinal symbiosis
This project aims to explore the regulatory mechanisms of intestinal bacteria and their symbiotic relationship with hosts using Drosophila to enhance understanding of gut metabolism and health.
T cell regulation by fed state bacterial metabolites
This project aims to identify immunoregulatory bacterial molecules produced in response to food intake, enhancing understanding of gut microbiome tolerance mechanisms and their impact on intestinal health.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
MicroBioDx: karakterisatie van microbioom-gastheer interactiesTenWise en Predica ontwikkelen de MicroBioD om de complexe samenstelling van micro-organismen te analyseren en gerichte behandelingen voor dysbiose te faciliteren. | Mkb-innovati... | € 143.080 | 2021 | Details |
MicroBioDx: karakterisatie van microbioom-gastheer interacties
TenWise en Predica ontwikkelen de MicroBioD om de complexe samenstelling van micro-organismen te analyseren en gerichte behandelingen voor dysbiose te faciliteren.